Abstract
Introduction: Early-onset Parkinsonism is a rare complication of phenylketonuria (PKU), a metabolic disorder marked by elevated phenylalanine and reduced tyrosine levels. This biochemical imbalance leads to dopamine deficiency in the basal ganglia, contributing to
References
Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417– 1427. doi:10.1016/S0140-6736(10)60961-0.
Diamond A, Prevor MB, Callender G, Druin DP. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Neurotoxicol Teratol. 1997;19(5):447–458. doi:10.1016/S0892-0362(97)00097-7.
van Vliet D, van Wegberg AMJ, Ahring KK, Bélanger-Quintana A, Blau N, Bosch AM, et al. Can adult patients with phenylketonuria adhere to diet? A systematic review. Mol Genet Metab. 2018;124(1):1–10. doi:10.1016/j.ymgme.2018.02.009.
Jaulent, P. et al. (2019) 'Neurological manifestations in adults with phenylketonuria:
New cases and review of the literature', Journal of Neurology, 267(2), pp. 531–542.
doi:10.1007/s00415-019-09608-2.
Phenylketonuria’ (2017) Progressive Brain Disorders in Childhood, pp. 99–102. doi:10.1017/9781107323704.028.
Velema M, Boot E, Engelen M, Hollak C. Parkinsonism in phenylketonuria: a consequence of dopamine depletion? JIMD Reports. 2015;20:35–38. doi:10.1007/8904_2014_386.
